Navigation Links
Diabetes Advocates Urge Members of Congress to Support Creation of National Diabetes Coordinator
Date:3/11/2008

NBA Hall-of-Famer Dominique Wilkins Speaks on Behalf of People with

Diabetes During Congressional Briefing

WASHINGTON, March 11 /PRNewswire-USNewswire/ -- NBA Hall-of-Famer Dominique Wilkins of the Atlanta Hawks urged Members of Congress to support a bill that will develop a national strategy to reduce diabetes and its complications in the U.S. Wilkins was joined today at a briefing on Capitol Hill by a coalition of diabetes advocates that included Congressman Jay Inslee (D-WA) and members of the American Association of Clinical Endocrinologists, American Association of Diabetes Educators and National Changing Diabetes(R) Program.

The National Diabetes Coordinator Act of 2008 (HR 4836), which amends the Public Health Service Act, would create the position of a National Diabetes Coordinator. This Coordinator would develop a national strategy to reduce the incidence of diabetes, develop a measurement tool to track progress, and provide leadership and coordination between government agencies and across public and private sectors to maximize impact. The bill was introduced in the House of Representatives by Representative Inslee on December 18, 2007.

"After I discovered I had diabetes, I made a personal commitment to motivate people to get screened and make positive lifestyle changes that can improve their health and their lives," said Dominique Wilkins, who discovered he had type-2 diabetes in 2000. "But without strong federal leadership on this issue, the human and economic costs will continue to mount."

An estimated 20.8 million Americans, or 7 percent of the population, have diabetes. Of the total, 6.2 million people remain undiagnosed. About 1.5 million new cases of diabetes are diagnosed each year in the United States(1). A study released by the National Changing Diabetes(R) Program in 2007 estimates that one out of every eight federal health dollars -- $80 billion -- is spent treating people with diabetes(2).

"Diabetes is an escalating health crisis in the United States that can't be ignored," said Representative Jay Inslee (D-Wash.), a member of the House Energy and Commerce Committee. "Unless we do something to reverse current trends, more and more of America's children will develop the disease during the course of their lifetime."

Research shows that efforts focused on diabetes prevention and early treatment can save lives and dollars; yet, the federal government spends less than $4 billion total on prevention and health promotion across all disease states(3). Investing more in prevention can help reduce the number of lives lost and the costs associated with diabetes.

"The National Diabetes Coordinator Act directly supports a principal consensus recommendation from important organizations in the healthcare community -- calling for increased federal leadership," said Jerzy Gruhn, President of Novo Nordisk. "Novo Nordisk, through the National Changing Diabetes(R) Program, is dedicated to helping defeat diabetes by supporting coordinated programs among the public and private sector to improve diabetes prevention and treatment."

"We support the efforts of Rep. Inslee to improve existing efforts for reducing diabetes and create new opportunities for the federal government to improve national leadership on this disease," said Richard Hellman, MD, the president of the American Association of Clinical Endocrinologists.

"The American Association of Diabetes Educators supports the National Diabetes Coordinator Act and the effort behind it to improve the prevention, detection and care of diabetes in the United States," said Amparo Gonzalez, RN, BSN, CDE, the president of the American Association of Diabetes Educators.

About the National Changing Diabetes(R) Program

The National Changing Diabetes(R) Program (NCDP) is a multi-faceted initiative that brings together innovators in diabetes education, treatment and policy to improve the lives of people with diabetes. NCDP strives to create change in the U.S. health care system to provide dramatic improvement in the prevention and care of diabetes. Launched in 2005, NCDP is a program of Novo Nordisk. For more information, please visit http://www.ncdp.com.

About Novo Nordisk

Novo Nordisk is a healthcare company with an 85-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to economic success, environmental soundness, and social responsibility to employees and customers. With headquarters in Denmark, Novo Nordisk employs more than 26,000 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.

1. American Diabetes Association. "About diabetes,"

http://www.diabetes.org/about-diabetes.jsp, Website accessed March

2008.

2. National Changing Diabetes Program. Study of Federal Spending on

Diabetes: An Opportunity for Change. Available at: http://www.ncdp.com/downloads/fedSpendRpt/FederalSpendingReport_6-6-07.pdf.

Accessed March 2008.

3. IBID


'/>"/>
SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Adverse housing conditions contribute to diabetes risk
2. RAND finds cases of undiagnosed diabetes drop sharply
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Discovery of sugar sensor in intestine could benefit diabetes
6. Despite overeating, morbidly obese mice gain protection against diabetes
7. Heart Attack Boosts Diabetes Risk
8. Obesity Doesnt Always Equal Diabetes
9. Sugary Sodas High in Diabetes-Linked Compound
10. Treating diabetes during pregnancy can break link to childhood obesity
11. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... City, UT (PRWEB) , ... February 05, 2016 , ... ... Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, specialist in ... Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior TV show, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its fiscal year and fourth quarter ... --> GAAP results: Revenue for the fourth quarter ... 4.1% from the third quarter of 2015, and up ... 2014. Revenue for the year ended December 31, 2015 was ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: